戒烟链接一项随机对照试验的结果:在同伴研究员的协助下,将接受精神健康服务的人转介到量身定制的戒烟热线进行烟草治疗。

IF 4 2区 医学 Q1 PSYCHIATRY Australian and New Zealand Journal of Psychiatry Pub Date : 2024-03-01 Epub Date: 2023-06-23 DOI:10.1177/00048674231181039
Amanda L Baker, Kristen McCarter, Alyna Turner, Catherine Segan, David Castle, Lisa Brophy, Ron Borland, Peter J Kelly, Billie Bonevski, Donita Baird, Sacha Filia, John Attia, Stuart Szwec, Kerrin Palazzi, Sarah L White, Jill M Williams, Anna L Wrobel, Andrew Ireland, Karinna Saxby, Peter Ghijben, Dennis Petrie, Rohan Sweeney
{"title":"戒烟链接一项随机对照试验的结果:在同伴研究员的协助下,将接受精神健康服务的人转介到量身定制的戒烟热线进行烟草治疗。","authors":"Amanda L Baker, Kristen McCarter, Alyna Turner, Catherine Segan, David Castle, Lisa Brophy, Ron Borland, Peter J Kelly, Billie Bonevski, Donita Baird, Sacha Filia, John Attia, Stuart Szwec, Kerrin Palazzi, Sarah L White, Jill M Williams, Anna L Wrobel, Andrew Ireland, Karinna Saxby, Peter Ghijben, Dennis Petrie, Rohan Sweeney","doi":"10.1177/00048674231181039","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to test the effectiveness of a tailored quitline tobacco treatment ('Quitlink') among people receiving support for mental health conditions.</p><p><strong>Methods: </strong>We employed a prospective, cluster-randomised, open, blinded endpoint design to compare a control condition to our 'Quitlink' intervention. Both conditions received a brief intervention delivered by a peer researcher. Control participants received no further intervention. Quitlink participants were referred to a tailored 8-week quitline intervention delivered by dedicated Quitline counsellors plus combination nicotine replacement therapy. The primary outcome was self-reported 6 months continuous abstinence from end of treatment (8 months from baseline). Secondary outcomes included additional smoking outcomes, mental health symptoms, substance use and quality of life. A within-trial economic evaluation was conducted.</p><p><strong>Results: </strong>In total, 110 participants were recruited over 26 months and 91 had confirmed outcomes at 8 months post baseline. There was a difference in self-reported prolonged abstinence at 8-month follow-up between Quitlink (16%, <i>n</i> = 6) and control (2%, <i>n</i> = 1) conditions, which was not statistically significant (OR = 8.33 [0.52, 132.09] <i>p</i> = 0.131 available case). There was a significant difference in favour of the Quitlink condition on 7-day point prevalence at 2 months (OR = 8.06 [1.27, 51.00] <i>p</i> = 0.027 available case). Quitlink costs AU$9231 per additional quit achieved.</p><p><strong>Conclusion: </strong>The Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"260-276"},"PeriodicalIF":4.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903138/pdf/","citationCount":"0","resultStr":"{\"title\":\"'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.\",\"authors\":\"Amanda L Baker, Kristen McCarter, Alyna Turner, Catherine Segan, David Castle, Lisa Brophy, Ron Borland, Peter J Kelly, Billie Bonevski, Donita Baird, Sacha Filia, John Attia, Stuart Szwec, Kerrin Palazzi, Sarah L White, Jill M Williams, Anna L Wrobel, Andrew Ireland, Karinna Saxby, Peter Ghijben, Dennis Petrie, Rohan Sweeney\",\"doi\":\"10.1177/00048674231181039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The aim of this study was to test the effectiveness of a tailored quitline tobacco treatment ('Quitlink') among people receiving support for mental health conditions.</p><p><strong>Methods: </strong>We employed a prospective, cluster-randomised, open, blinded endpoint design to compare a control condition to our 'Quitlink' intervention. Both conditions received a brief intervention delivered by a peer researcher. Control participants received no further intervention. Quitlink participants were referred to a tailored 8-week quitline intervention delivered by dedicated Quitline counsellors plus combination nicotine replacement therapy. The primary outcome was self-reported 6 months continuous abstinence from end of treatment (8 months from baseline). Secondary outcomes included additional smoking outcomes, mental health symptoms, substance use and quality of life. A within-trial economic evaluation was conducted.</p><p><strong>Results: </strong>In total, 110 participants were recruited over 26 months and 91 had confirmed outcomes at 8 months post baseline. There was a difference in self-reported prolonged abstinence at 8-month follow-up between Quitlink (16%, <i>n</i> = 6) and control (2%, <i>n</i> = 1) conditions, which was not statistically significant (OR = 8.33 [0.52, 132.09] <i>p</i> = 0.131 available case). There was a significant difference in favour of the Quitlink condition on 7-day point prevalence at 2 months (OR = 8.06 [1.27, 51.00] <i>p</i> = 0.027 available case). Quitlink costs AU$9231 per additional quit achieved.</p><p><strong>Conclusion: </strong>The Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.</p>\",\"PeriodicalId\":8589,\"journal\":{\"name\":\"Australian and New Zealand Journal of Psychiatry\",\"volume\":\" \",\"pages\":\"260-276\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903138/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Australian and New Zealand Journal of Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/00048674231181039\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian and New Zealand Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00048674231181039","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

研究目的本研究旨在测试在接受心理健康支持的人群中开展有针对性的戒烟热线治疗("Quitlink")的效果:我们采用了一种前瞻性、分组随机、开放、盲点设计的方法,将对照组与 "戒烟热线 "干预组进行比较。两种情况都接受了由同伴研究员提供的简短干预。对照组参与者没有接受进一步的干预。而 "戒烟链接 "参与者则被转介到由专门的戒烟热线顾问提供的为期8周的定制戒烟热线干预以及尼古丁替代组合疗法。主要结果是自治疗结束(自基线起8个月)起连续戒烟6个月的自我报告。次要结果包括其他吸烟结果、心理健康症状、药物使用和生活质量。此外,还进行了试验内经济评估:共招募了 110 名参与者,历时 26 个月,其中 91 人在基线后 8 个月确认了治疗结果。在 8 个月的随访中,"戒毒链接"(16%,n = 6)与对照组(2%,n = 1)在自我报告的长期戒断率方面存在差异,但无统计学意义(OR = 8.33 [0.52, 132.09] p = 0.131)。在 2 个月的 7 天点数流行率方面,"戒烟链接 "方案与 "戒烟链接 "方案存在明显差异(OR = 8.06 [1.27, 51.00] p = 0.027 可用案例)。每多实现一次戒烟,Quitlink 的成本为 9231 澳元:结论:"戒烟链接 "干预并没有明显提高基线后 8 个月的长期戒烟率。然而,"Quitlink "干预的参与率和满意度都很高。虽然 "戒毒链接 "干预措施的作用力不足,但它仍显示出了良好的前景。因此,有必要进行一项有动力的试验,以确定其在提高长期戒烟率方面的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.

Objective: The aim of this study was to test the effectiveness of a tailored quitline tobacco treatment ('Quitlink') among people receiving support for mental health conditions.

Methods: We employed a prospective, cluster-randomised, open, blinded endpoint design to compare a control condition to our 'Quitlink' intervention. Both conditions received a brief intervention delivered by a peer researcher. Control participants received no further intervention. Quitlink participants were referred to a tailored 8-week quitline intervention delivered by dedicated Quitline counsellors plus combination nicotine replacement therapy. The primary outcome was self-reported 6 months continuous abstinence from end of treatment (8 months from baseline). Secondary outcomes included additional smoking outcomes, mental health symptoms, substance use and quality of life. A within-trial economic evaluation was conducted.

Results: In total, 110 participants were recruited over 26 months and 91 had confirmed outcomes at 8 months post baseline. There was a difference in self-reported prolonged abstinence at 8-month follow-up between Quitlink (16%, n = 6) and control (2%, n = 1) conditions, which was not statistically significant (OR = 8.33 [0.52, 132.09] p = 0.131 available case). There was a significant difference in favour of the Quitlink condition on 7-day point prevalence at 2 months (OR = 8.06 [1.27, 51.00] p = 0.027 available case). Quitlink costs AU$9231 per additional quit achieved.

Conclusion: The Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.00
自引率
2.20%
发文量
149
审稿时长
6-12 weeks
期刊介绍: Australian & New Zealand Journal of Psychiatry is the official Journal of The Royal Australian and New Zealand College of Psychiatrists (RANZCP). The Australian & New Zealand Journal of Psychiatry is a monthly journal publishing original articles which describe research or report opinions of interest to psychiatrists. These contributions may be presented as original research, reviews, perspectives, commentaries and letters to the editor. The Australian & New Zealand Journal of Psychiatry is the leading psychiatry journal of the Asia-Pacific region.
期刊最新文献
Self-poisoning in young Australians: The impact of COVID-19 and recent trends following easing of restrictions. Letters to the Editor: Differential effects of access restriction to a highway bridge on suicide numbers by jumping. Extending the reach of involuntary treatment to substance use disorders: Is it 'compassionate' or coercive care? Policy implications of the 2020-22 Australian study of mental health and wellbeing. Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1